891 Beta-adrenergic blockade licenses the use of immunotherapy in primary and metastatic brain tumors

• Peter E Fecci,
• Selena J Lorrey,
• Lucas P Wachsmuth,
• Jessica Waibl Polania,
• Alexandra Hoyt-Miggelbrink,
• John Finlay,
• Mackenzie Price,
• Corey Neff,
• Xiuyu Cui,
• Emily Lerner,
• Daniel Wilkinson,
• Kelly Hotchkiss,
• Ethan Srinivasan,
• Quinn T Ostrom

Affiliations

Peter E Fecci

3Duke Cancer Institute, Durham, NC, USA

Selena J Lorrey

1Duke University, Durham, NC, USA

Lucas P Wachsmuth

1Duke University, Durham, NC, USA

Jessica Waibl Polania

1Duke University, Durham, NC, USA

Alexandra Hoyt-Miggelbrink

1Duke University, Durham, NC, USA

John Finlay

1Duke University, Durham, NC, USA

Mackenzie Price

1Duke University, Durham, NC, USA

Corey Neff

1Duke University, Durham, NC, USA

Xiuyu Cui

1Duke University, Durham, NC, USA

Emily Lerner

1Duke University, Durham, NC, USA

Daniel Wilkinson

1Duke University, Durham, NC, USA

Kelly Hotchkiss

1Duke University, Durham, NC, USA

Ethan Srinivasan

2Johns Hopkins University, Baltimore, MD, USA

Quinn T Ostrom

1Duke University, Durham, NC, USA